iX Biopharma clinches Indonesian patent for new drug delivery technology
This the 6th country to grant a patent.
Homegrown specialty pharmaceutical company iX Biopharma has been granted a patent in Indonesia for its WaferiX drug delivery technology. The patent will expire on 26 October 2030.
Indonesia is the sixth country to grant iX Biopharma a patent for WaferiX. The comapny was recently granted its Japanese patent in September 2015, while counterpart patents have already been granted in Australia, Malaysia, New Zealand and Singapore.
Pending applications are currently under examination in major markets including the US, Europe, China, India, Canada, South Korea, South Africa, Hong Kong, and Thailand.